Total Health, Inc. is an AI-assisted clinical decision support platform focused on precision medicine for genetic diseases. It is not positioned as a consumer-facing health app for patients, but as technical infrastructure for licensed clinical service providers. The platform helps coordinate genetic testing, deliver genetic counseling services, and perform structured reasoning and analysis on genetic data. It has a clinical collaboration background with Mount Sinai Health System, with initial focus areas including hereditary cancer genetic testing and scalable genetic counseling.
The core of the product is its Clinical Decision Logic Graph, which emphasizes “structured reasoning” and a “non-black-box” approach. Its Decision Lineage can trace results back to underlying assumptions, with trackable nodes; Live Trace supports immutable auditing and historical state review; and Clinical Report Generation can turn complex graph data into clinical guidance for care teams. Its AI capabilities mainly appear in reasoning-based interpretation of genetic data and generation of care pathways, but the website does not disclose the specific model architecture, training data, validation metrics, or accuracy rates.
The public pages do not provide pricing, plans, free trials, or payment methods. They only offer a mailing list subscription and early access opportunities. API and system integration details are also not clearly explained, with no mention of EHR/EMR, LIS, SDKs, or open APIs. The text only suggests possible collaboration with clinical partners, CLIA-certified laboratory partners, and cloud service providers.
Its strengths are a focused use case and strong awareness of clinical compliance. It emphasizes HIPAA, GINA, New York State genetic testing regulations, written informed consent, end-to-end encryption, and not selling personal data. Its auditable reasoning chain is also well suited to high-risk medical settings. The limitations are that the public information is still largely vision- and compliance-oriented, with limited clinical validation, product demos, real-world deployment cases, or commercialization details. The terms also make clear that the platform does not replace professional medical advice, and that outputs must be independently evaluated by qualified physicians.
It is better suited to healthcare institutions, genetic counseling teams, oncology/genetics clinicians, and partners looking to build care pathways around genetic testing. It is not suitable for ordinary users to use for self-diagnosis. Access from China cannot be determined from the available text alone, and payment options as well as cross-border medical compliance are not disclosed. If deployed in China, additional issues would need to be considered, including local genetic data requirements, medical device software regulation, cross-border data transfer, and Chinese-language report support.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on trytotalhealth.com official site.
trytotalhealth.com is an Unknown AI Apps provider. TG4G tracks its product information, an overall rating of 6.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach trytotalhealth.com directly.